| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 2 | +10.9M | 73.8% | $0.11 | +$1.17M |
| Sells | 2 | -3.87M | 26.2% | $0.19 | -$726K |
| Net | 0 | +7.02M | 47.6% | +$443K |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Yair Schneid | 10%+ Owner | $2.1M | +$609K | +40.8% | Apr 17, 2024 |
| Rochel Soffer | 10%+ Owner | $1.15M | Apr 16, 2024 | ||
| Nancy T. Chang | Director, 10%+ Owner | $500K | +$500K | Dec 30, 2024 | |
| Altamont Pharmaceutical Holdings, LLC | 10%+ Owner | $158K | -$722K | -82.1% | Dec 31, 2023 |
| Mel Sorensen | President and CEO, Director | $19.1K | -$4.83K | -20.2% | Aug 16, 2024 |
| Mark Bachleda | Chief Commercial Officer | $11.8K | Mar 16, 2023 | ||
| Chris Degnan | Chief Financial Officer | $10.7K | Mar 13, 2023 | ||
| Lawrence M. Alleva | Director | Jul 1, 2023 | |||
| Linda West | Director | Jul 1, 2023 | |||
| Emmett Cunningham | Director | Jun 14, 2023 | |||
| Eugene P. Kennedy | Chief Medical Officer | Feb 25, 2023 | |||
| Holmlund Jon T | Chief Medical Officer | Feb 28, 2022 | |||
| R. Michael Friedman | Director | Dec 30, 2024 | |||
| Michael Powell | Director | Jun 14, 2023 | |||
| Kevin G. Lokay | Director | Jun 14, 2023 | |||
| Robert A. Beardsley | Chief Operating Officer | Feb 25, 2023 | |||
| Jennifer Evans Stacey | Chief Legal & Compliance Officer | Feb 25, 2023 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|